Cargando…
Efficacy and safety results from the first pivotal phase 3 randomized controlled trial of mdma-assisted psychotherapy for treatment of severe chronic PTSD
INTRODUCTION: Posttraumatic stress disorder is a prevalent mental health condition with substantial impact on daily functioning that lacks sufficient treatment options. Previous research has led to the designation of 3,4-methylenedioxymethamphetamine (MDMA) as a Breakthrough Therapy for treatment of...
Autor principal: | Van Der Kolk, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471528/ http://dx.doi.org/10.1192/j.eurpsy.2021.391 |
Ejemplares similares
-
MDMA-assisted psychotherapy for the treatment of PTSD
por: Reiff, Collin M., et al.
Publicado: (2020) -
A comparison of mdma-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
por: Illingworth, B., et al.
Publicado: (2021) -
Psychotherapy-supported MDMA treatment for PTSD
por: Krystal, John H., et al.
Publicado: (2021) -
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
por: Marseille, Elliot, et al.
Publicado: (2020) -
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
por: Morgan, Louise
Publicado: (2020)